China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 26.55
(-0.19%)
CNY 26.55
(-0.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | -19.62% |
| 2022 | 985.59 Million CNY | -5.31% |
| 2021 | 1.04 Billion CNY | -7.67% |
| 2020 | 1.12 Billion CNY | -9.46% |
| 2019 | 1.24 Billion CNY | 31.35% |
| 2018 | 947.89 Million CNY | 71.04% |
| 2017 | 554.19 Million CNY | 97.75% |
| 2016 | 280.24 Million CNY | 50.34% |
| 2015 | 186.41 Million CNY | 28.24% |
| 2014 | 145.36 Million CNY | 133.7% |
| 2013 | 62.2 Million CNY | -1.21% |
| 2012 | 62.96 Million CNY | 22.51% |
| 2011 | 51.39 Million CNY | 22.97% |
| 2010 | 41.79 Million CNY | 16.28% |
| 2009 | 35.94 Million CNY | 60.03% |
| 2008 | 22.45 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 156.13 Million CNY | -68.82% |
| 2024 Q3 | 152.15 Million CNY | -14.3% |
| 2024 Q2 | 135.29 Million CNY | -13.35% |
| 2023 Q3 | 207 Million CNY | -11.86% |
| 2023 Q2 | 234.87 Million CNY | 8.17% |
| 2023 Q1 | 217.13 Million CNY | -16.88% |
| 2023 FY | 792.18 Million CNY | -19.62% |
| 2023 Q4 | 500.74 Million CNY | 141.9% |
| 2022 Q4 | 261.24 Million CNY | 1.44% |
| 2022 Q1 | 224.69 Million CNY | -20.36% |
| 2022 Q2 | 242.11 Million CNY | 7.75% |
| 2022 FY | 985.59 Million CNY | -5.31% |
| 2022 Q3 | 257.54 Million CNY | 6.37% |
| 2021 Q1 | 238.11 Million CNY | -28.15% |
| 2021 Q4 | 282.13 Million CNY | 6.8% |
| 2021 Q3 | 264.17 Million CNY | 3.03% |
| 2021 Q2 | 256.41 Million CNY | 7.68% |
| 2021 FY | 1.04 Billion CNY | -7.67% |
| 2020 FY | 1.12 Billion CNY | -9.46% |
| 2020 Q4 | 331.42 Million CNY | 12.32% |
| 2020 Q3 | 295.08 Million CNY | 12.82% |
| 2020 Q2 | 261.54 Million CNY | 9.34% |
| 2020 Q1 | 239.21 Million CNY | -36.32% |
| 2019 Q2 | 303.72 Million CNY | 16.14% |
| 2019 Q4 | 375.65 Million CNY | 23.52% |
| 2019 Q1 | 261.5 Million CNY | -8.13% |
| 2019 FY | 1.24 Billion CNY | 31.35% |
| 2019 Q3 | 304.13 Million CNY | 0.14% |
| 2018 Q2 | 220.84 Million CNY | 12.89% |
| 2018 Q4 | 284.64 Million CNY | 15.34% |
| 2018 FY | 947.89 Million CNY | 71.04% |
| 2018 Q3 | 246.77 Million CNY | 11.74% |
| 2018 Q1 | 195.62 Million CNY | -18.28% |
| 2017 FY | 554.19 Million CNY | 97.75% |
| 2017 Q2 | 124.32 Million CNY | 82.59% |
| 2017 Q3 | 122.39 Million CNY | -1.55% |
| 2017 Q1 | 68.08 Million CNY | -25.87% |
| 2017 Q4 | 239.38 Million CNY | 95.58% |
| 2016 FY | 280.24 Million CNY | 50.34% |
| 2016 Q4 | 91.84 Million CNY | 41.34% |
| 2016 Q1 | 57.24 Million CNY | -10.56% |
| 2016 Q2 | 66.18 Million CNY | 15.62% |
| 2016 Q3 | 64.97 Million CNY | -1.81% |
| 2015 Q1 | 37.81 Million CNY | -17.09% |
| 2015 Q3 | 40.69 Million CNY | -7.33% |
| 2015 Q4 | 63.99 Million CNY | 57.28% |
| 2015 Q2 | 43.9 Million CNY | 16.12% |
| 2015 FY | 186.41 Million CNY | 28.24% |
| 2014 Q2 | 34.71 Million CNY | 15.98% |
| 2014 Q1 | 29.93 Million CNY | 148.0% |
| 2014 FY | 145.36 Million CNY | 133.7% |
| 2014 Q4 | 45.61 Million CNY | 29.94% |
| 2014 Q3 | 35.1 Million CNY | 1.1% |
| 2013 Q3 | 17.89 Million CNY | 3.35% |
| 2013 Q4 | 12.07 Million CNY | -32.54% |
| 2013 FY | 62.2 Million CNY | -1.21% |
| 2013 Q1 | 14.92 Million CNY | -8.8% |
| 2013 Q2 | 17.31 Million CNY | 16.03% |
| 2012 FY | 62.96 Million CNY | 22.51% |
| 2012 Q4 | 16.36 Million CNY | -8.88% |
| 2012 Q2 | 15.84 Million CNY | 23.89% |
| 2012 Q3 | 17.95 Million CNY | 13.31% |
| 2012 Q1 | 12.79 Million CNY | -21.94% |
| 2011 Q1 | 9.21 Million CNY | 0.0% |
| 2011 FY | 51.39 Million CNY | 22.97% |
| 2011 Q2 | 16.44 Million CNY | 78.53% |
| 2011 Q3 | 9.35 Million CNY | -43.12% |
| 2011 Q4 | 16.38 Million CNY | 75.19% |
| 2010 FY | 41.79 Million CNY | 16.28% |
| 2009 FY | 35.94 Million CNY | 60.03% |
| 2008 FY | 22.45 Million CNY | 0.0% |